Skip to main content
Caplight Logo









Crely

Crely

Private
Oxnard, CaliforniaHealthcare & Life Scienceshttps://crely.ai

Last Round

Accelerator

Jun 5, 2025

Company Overview

Crely operates in Healthcare & Life Sciences and is based in Oxnard, California. Its latest recorded funding round was an Accelerator round in June 2025.

Crely is a medical technology company that develops AI-powered early warning systems and wearable medical devices to predict and detect surgical site infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Crely Comparables

Compare Crely with similar companies based on industry and business-model similarity.

Crely comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Predictive Healthcare
83%
BioIntelliSense
77%
Healthplus.ai
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Crely Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 5, 2025
AcceleratorAug 25, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Arun Sethuraman

Founder & CEO

Founding Team

For institutional investors. Book with your work email.

Crely Investors

Notable investors and investment history

Crely investors
InvestorRounds
MedTech InnovatorAccelerator
Harvard Business School New Venture CompetitionAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors increased 121% MoM, reaching 3.6K.

  • Nov 7, 2025

    Monthly visitors grew 42% MoM, reaching 1.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Crely Filings

Explore SEC and related filing metadata, where available.

Crely filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Crely's valuation, stock price, and market status.

Is Crely a public or private company?

Crely is a private company.

What is the current stock price of Crely?

Crely is a private company, so its shares have no public market price. Caplight tracks Crely's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Crely worth (valuation)?

Valuation information for Crely is not publicly available.

Can I buy Crely stock?

Crely shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Crely's last funding round?

Crely's most recent funding round was Accelerator on June 5, 2025.

Who are the main investors in Crely?

Key investors in Crely include MedTech Innovator.

Will Crely IPO soon?

No public IPO plans have been announced for Crely.

How can I track Crely secondary market activity?

Caplight tracks bids, offers, and trades in Crely's shares on secondary markets.

Firmographic Details

HeadquartersOxnard, California
Employee Range7
Year Founded2018
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?